This year's Nobel Prize in Physiology or Medicine has been awarded to three scientists for their work on regulatory T-cells (Tregs), research that has fuelled a well-stocked pipeline of potential new ...

Novartis has claimed accelerated approval from the FDA for a second indication for Fabhalta – IgA nephropathy (IgAN) – as it charts a course to blockbuster sales for the drug. The US regulator has ...